Kelsee

Dienogest/Ethinylestradiol, the active ingredient in Kelsee, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents ovulation by regulating hormonal cycles and thereby reduces the risk of pregnancy for women seeking reliable birth control.

GNH USA supplies Kelsee as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets. The product is manufactured under strict GMP guidelines to meet EU standards and is distributed with comprehensive documentation.

Kelsee, a combined oral contraceptive, is indicated for hormonal contraception.

- Prevention of pregnancy: provides reliable contraceptive protection for women of reproductive age. - Regulation of menstrual cycle: helps achieve more predictable bleeding patterns. - Reduction of ovarian cyst formation: lowers the incidence of functional ovarian cysts in users.

Kelsee may cause a range of adverse reactions. Patients should be informed of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: often transient and mild. - Breakthrough bleeding: irregular spotting between periods. - Mood changes: occasional irritability or mood swings.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein clot or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Severe hypertension: sudden rise in blood pressure. - Liver tumor: benign hepatic adenoma. - Allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Kelsee, clinicians should evaluate several safety considerations.

- Assess cardiovascular risk: review history of thrombosis or clotting disorders. - Avoid in smokers over 35 years: smoking markedly increases thrombotic risk. - Consider liver function: contraindicated in active liver disease or severe hepatic impairment. - Monitor blood pressure: oral contraceptives may elevate systolic and diastolic values. - Review concomitant medications: potential interactions can affect efficacy. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Kelsee can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce hormone levels. - Rifampin (antibiotic): can decrease contraceptive efficacy. - Certain protease inhibitors (e.g., ritonavir): may increase hormone concentrations and risk of side effects.

Moderate Interactions (Monitor Closely): - St. John’s wort: may lower effectiveness through enzyme induction. - Antifungals such as ketoconazole: can raise hormone levels, requiring monitoring. - Diuretics: may affect fluid balance and blood pressure, necessitating observation.